MA50763A - Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires - Google Patents

Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires

Info

Publication number
MA50763A
MA50763A MA050763A MA50763A MA50763A MA 50763 A MA50763 A MA 50763A MA 050763 A MA050763 A MA 050763A MA 50763 A MA50763 A MA 50763A MA 50763 A MA50763 A MA 50763A
Authority
MA
Morocco
Prior art keywords
disorders
amino acid
treatment methods
acid compositions
muscle diseases
Prior art date
Application number
MA050763A
Other languages
English (en)
Inventor
Raffi Afeyan
William Comb
Michael Hamill
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of MA50763A publication Critical patent/MA50763A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA050763A 2016-12-19 2017-12-19 Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires MA50763A (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662436073P 2016-12-19 2016-12-19
US201762443205P 2017-01-06 2017-01-06
US201762491776P 2017-04-28 2017-04-28
US201762545358P 2017-08-14 2017-08-14
US201762576321P 2017-10-24 2017-10-24

Publications (1)

Publication Number Publication Date
MA50763A true MA50763A (fr) 2019-10-23

Family

ID=61025047

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050763A MA50763A (fr) 2016-12-19 2017-12-19 Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires

Country Status (21)

Country Link
US (3) US20180207119A1 (fr)
EP (1) EP3554493A1 (fr)
JP (1) JP2020502183A (fr)
KR (1) KR20190099243A (fr)
CN (1) CN110267655A (fr)
AU (1) AU2017379825A1 (fr)
BR (1) BR112019012476A2 (fr)
CA (1) CA3046558A1 (fr)
CL (1) CL2019001685A1 (fr)
CO (1) CO2019006292A2 (fr)
CU (1) CU20190057A7 (fr)
EC (1) ECSP19043725A (fr)
IL (1) IL267210A (fr)
JO (1) JOP20190147A1 (fr)
MA (1) MA50763A (fr)
MX (1) MX2019007352A (fr)
PE (1) PE20191206A1 (fr)
PH (1) PH12019501339A1 (fr)
TW (1) TWI780096B (fr)
WO (1) WO2018118957A1 (fr)
ZA (1) ZA201903581B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US11617731B2 (en) 2017-04-28 2023-04-04 Axcella Health, Inc. Amino acid compositions and their use for the treatment of traumatic brain injury
JP7370960B2 (ja) * 2017-08-14 2023-10-30 アクセラ・ヘルス・インコーポレイテッド 神経細胞損傷の治療のためのアミノ酸組成物
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
AR115581A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Métodos de preparación de composiciones de aminoácidos
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
WO2019246310A1 (fr) * 2018-06-20 2019-12-26 Axcella Health Inc. Compositions et procédés pour la réduction ou le traitement d'une inflammation
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
CN112752575A (zh) * 2018-09-27 2021-05-04 雀巢产品有限公司 组氨酸、甘氨酸和其它氨基酸用于预防胰岛素抗性和/或糖尿病的用途
WO2020245299A1 (fr) * 2019-06-07 2020-12-10 Société des Produits Nestlé S.A. Compositions et procédés utilisant un ou plusieurs acides aminés induisant l'autophagie pour potentialiser l'effet musculo-squelettique d'un ou plusieurs acides aminés anabolisants
US20220184015A1 (en) * 2019-06-20 2022-06-16 Societe Des Produits Nestle S.A. Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids on bone health
IT201900010437A1 (it) 2019-06-28 2020-12-28 Dompe Farm Spa Composizione per il trattamento del deperimento muscolare
KR102338447B1 (ko) * 2019-09-24 2021-12-14 마이오텍사이언스 주식회사 비천연 아미노산을 함유하는 근감소증의 예방 또는 치료용 약학적 조성물
KR102456270B1 (ko) * 2019-09-24 2022-10-19 마이오텍사이언스 주식회사 비천연 아미노산 유도체를 함유하는 근감소증의 예방 또는 치료용 약학적 조성물
US20220331290A1 (en) * 2019-09-24 2022-10-20 Myo-Tec-Sci Pharmaceutical composition for preventing or treating sarcopenia, containing unnatural amino acid
CN110801007A (zh) * 2019-12-17 2020-02-18 苟春虎 老年肌少症营养肽
WO2021178860A1 (fr) * 2020-03-06 2021-09-10 Axcella Health Inc. Compositions d'acides aminés et procédés de modulation de muscle et de myotube
JP7599753B2 (ja) * 2021-02-26 2024-12-16 イーエックス ヘルスケア インコーポレーテッド 皮膚由来エキソソームを通じて筋損失抑制又は筋生成促進効果を示す組成物
CN113288890B (zh) * 2021-06-21 2022-02-22 南方医科大学南方医院 N-乙酰-l-半胱氨酸在制备预防和/或治疗运动损伤的药物中的应用
WO2024026307A1 (fr) 2022-07-25 2024-02-01 Axcella Health Inc. Biomarqueur pour covid longue et fatigue
WO2024030909A1 (fr) 2022-08-01 2024-02-08 Axcella Health Inc. Biomarqueurs de réponse au traitement d'une composition d'acides aminés dans covid long
WO2025167857A1 (fr) * 2024-02-06 2025-08-14 南京纽邦生物科技有限公司 Procédé et composition pour renforcer ou améliorer la fonction musculaire et/ou améliorer les performances athlétiques et/ou prévenir ou atténuer la fatigue

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003521256A (ja) * 2000-02-01 2003-07-15 マッスルテク リサーチ アンド ディヴェロプメント インコーポレーション 無脂肪筋量及び筋力を増強するためのαリポ酸含有食物補充物質
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
WO2006009975A2 (fr) * 2004-06-22 2006-01-26 Maxim Pharmaceuticals, Inc. Utilisation d'histamine et de composes associes pour traiter des troubles de la fonction musculaire
EP1865944B1 (fr) * 2005-03-29 2018-08-29 Ajinomoto Co., Inc. Composition à base d'acides aminés utilisée pour prévenir ou remédier à la diminution de la masse musculaire squelettique de personnes âgées, comprenant de la L-leucine
JP2007023921A (ja) * 2005-07-19 2007-02-01 Toyota Motor Corp 内燃機関の制御装置
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
CN100518815C (zh) * 2007-02-15 2009-07-29 北京苏里曼医药科技有限公司 一种氨基酸组合物
HK1199378A1 (en) * 2011-08-19 2015-07-03 Musclepharm Corporation Compositions and methods for use in promoting lean body mass
JP2017501113A (ja) * 2013-10-23 2017-01-12 ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ アミノ酸によるｍＴＯＲＣ１の調節およびその使用

Also Published As

Publication number Publication date
CL2019001685A1 (es) 2019-08-30
KR20190099243A (ko) 2019-08-26
PH12019501339A1 (en) 2019-09-30
ECSP19043725A (es) 2019-07-31
US20180207119A1 (en) 2018-07-26
CO2019006292A2 (es) 2019-06-28
TW201827068A (zh) 2018-08-01
US20180169047A1 (en) 2018-06-21
CA3046558A1 (fr) 2018-06-28
AU2017379825A1 (en) 2019-06-13
CN110267655A (zh) 2019-09-20
IL267210A (en) 2019-08-29
WO2018118957A1 (fr) 2018-06-28
MX2019007352A (es) 2019-09-05
JP2020502183A (ja) 2020-01-23
PE20191206A1 (es) 2019-09-10
ZA201903581B (en) 2020-12-23
TWI780096B (zh) 2022-10-11
BR112019012476A2 (pt) 2020-04-14
US20180169046A1 (en) 2018-06-21
CU20190057A7 (es) 2020-02-04
JOP20190147A1 (ar) 2019-06-18
EP3554493A1 (fr) 2019-10-23

Similar Documents

Publication Publication Date Title
IL267210A (en) Amino acid compounds and methods for treating muscle diseases and disorders
MA51451A (fr) Compositions d'acides aminés et méthodes de traitement de maladies hépatiques
EP3458585A4 (fr) Procédés de thérapie génique pour des maladies et des affections liées à l'âge
MX375424B (es) Derivados de 1,1,1-trifluoro-3-hidroxipropan-2-il carbamato y derivados de 1,1,1-trifluoro-4- hidroxibutan-2-il carbamato como inhibidores de magl
EP3562514A4 (fr) Thérapie génique pour le traitement de la maladie de wilson
PL3405215T3 (pl) Sposoby leczenia choroby danona i innych zaburzeń autofagii
EA201992607A1 (ru) Твердые формы берберина урсодезоксихолата, их композиции и способы
EP3829569A4 (fr) Formulations de spinosyne pour le traitement de maladies oculaires et faciaux provoquées par demodex
EP3429605A4 (fr) Agent thérapeutique pour le traitement de maladies, notamment les maladies touchant le système nerveux central
EP3481958A4 (fr) Procédés et compositions de traitement de troubles et de maladies impliquant rdh12
EP2877184A4 (fr) Compositions et traitement pour maladies et troubles oculaires
EP2691102A4 (fr) Composition d'herbes pour le traitement de maladies neurologiques et l'amélioration des troubles de la mémoire
EP3507371A4 (fr) Méthodes et compositions pour traiter des maladies et des troubles du système nerveux
SG11202004971YA (en) Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
EP3649256A4 (fr) Procédés de traitement d'une inflammation et de maladies et troubles associés par inhibition de la protéine kinase alpha 1
MA44126A (fr) Méthodes de traitement de maladies et troubles pulmonaires
EP3270914C0 (fr) Composés et formes de traitement des troubles sexuels chez la femme
EP3672587A4 (fr) Compositions pharmaceutiques destinées au traitement d'affections ophtalmiques
EP3581175A4 (fr) Préparation d'administration de médicament pour le traitement de maladies mentales ou de troubles du système nerveux central
EP4058017A4 (fr) Formulations médicamenteuses et méthodes de traitement de troubles métaboliques
EP3377622A4 (fr) Libération ciblée dans des types de cellules d'intérêt de protéines thérapeutiques bioencapsulées dans des cellules végétales pour le traitement de maladies
IL280952A (en) Methods and drug compounds for the treatment of ophthalmic diseases
EP3341002A4 (fr) Composition à base d'herbes médicinales pour le traitement de maladies maculaires liées à l'âge
EP3341012A4 (fr) Procédés d'utilisation de l'interleukine-10 pour le traitement de maladies et de troubles
MA53636A (fr) Agent de traitement de troubles dermatologiques